Explore News
-
Common Arthritis Drugs Reduce Systemic Sjögren’s Disease Activity in 24 Weeks
Clinical trial shows significant reduction in disease activity with leflunomide and hydroxychloroquine
Clinical trial shows significant reduction in disease activity with leflunomide and hydroxychloroquine